Mohamed, Hossam TahaUntereiner, ValérieCinque, GianfeliceIbrahim, Sherif AbdelazizGötte, MartinNguyen, Nguyet QueRivet, RomainSockalingum, Ganesh D.Brézillon, Stéphane2020-10-032020-10-039/19/202014203049https://doi.org/10.3390/molecules25184300http://repository.msa.edu.eg/xmlui/handle/123456789/3806ScopusGlycosaminoglycans (GAGs)/proteoglycans (PGs) play a pivotal role in the metastasis of inflammatory breast cancer (IBC). They represent biomarkers and targets in diagnosis and treatment of different cancers including breast cancer. Thus, GAGs/PGs could represent potential prognostic/diagnostic biomarkers for IBC. In the present study, non-IBC MDA-MB-231, MCF7, SKBR3 cells and IBC SUM149 cells, as well as their GAG secretome were analyzed. The latter was measured in toto as dried drops with high-throughput (HT) Fourier Transform InfraRed (FTIR) spectroscopy and imaging. FTIR imaging was also employed to investigate single whole breast cancer cells while synchrotron-FTIR microspectroscopy was used to specifically target their cytoplasms. Data were analyzed by hierarchical cluster analysis and principal components analysis. Results obtained from HT-FTIR analysis of GAG drops showed that the inter-group variability enabled us to delineate between cell types in the GAG absorption range 1350–800 cm−1. Similar results were obtained for FTIR imaging of GAG extracts and fixed single whole cells. Synchrotron-FTIR data from cytoplasms allowed discrimination between non-IBC and IBC. Thus, by using GAG specific region, not only different breast cancer cell lines could be differentiated, but also non-IBC from IBC cells. This could be a potential diagnostic spectral marker for IBC detection useful for patient management. © 2020 by the authors. Licensee MDPI, Basel, Switzerlanden-USinflammatory breast cancerglycosaminoglycansproteoglycanssecretomeinfrared (micro)spectroscopyimagingsynchrotron-FTIRArticlehttps://doi.org/10.3390/molecules25184300